Beyond the Breaking News

Exclusive: U.S. hospitals turn down remdesivir supplies, limit use to sickest COVID-19 patients

United States News News

Exclusive: U.S. hospitals turn down remdesivir supplies, limit use to sickest COVID-19 patients
United States Latest News,United States Headlines

U.S. hospitals have turned down about a third of their allocated supplies of the COVID-19 drug remdesivir since July as need for the costly antiviral wanes, according to unpublished government statistics provided to Reuters by a U.S. pharmacists' group.

- U.S. hospitals have turned down about a third of their allocated supplies of the COVID-19 drug remdesivir since July as need for the costly antiviral wanes, according to unpublished government statistics provided to Reuters by a U.

S. pharmacists’ group. FILE PHOTO: An ampule of Ebola drug Remdesivir is pictured during a news conference at the University Hospital Eppendorf in Hamburg, Germany, April 8, 2020, as the spread of coronavirus disease continues. Ulrich Perrey/Pool via REUTERS/File Photomedicine to build inventory in case the pandemic accelerates over the winter. But they said current supplies are adequate, in part because they are limiting use to severely ill patients. The Food and Drug Administration has allowed more liberal remdesivir use, but 6 out of 8 major hospital systems contacted by Reuters said they were not using it for moderate cases. The slowdown suggests that a shortage of the drug is over and threatens Gilead’s efforts to expand use of remdesivir, which it sells under the brand name Veklury in some countries. The U.S. Department of Health and Human Services told hospitals and other healthcare organizations on Friday that between July 6 and September 8, state and territory public health systems accepted about 72% of the remdesivir they were offered, Michael Ganio, senior director of pharmacy practice and quality at the American Society of Health-System Pharmacists, told Reuters. Hospitals in turn took only about two-thirds of what states and territories accepted, he added. It was not immediately clear what happened to the surplus supplies.A surplus of remdesivir - which costs $3,120 for a 6-vial intravenous course - marks a turnaround from earlier in the pandemic, when supplies of the drug had fallen short of demand in some regions. Government-led distribution of remdesivir will expire at the end of September. Hospitals said they have little information on availability after that. Remdesivir was first authorized by the FDA in May for emergency use in COVID-19 patients hospitalized and on oxygen support after data showed that it helped shorten hospital recovery time. The agency last month expanded use to hospitalized patients who do not require oxygen support, based on data published in the JAMA medical journal showing that the drug provided a modest benefit for those patients.Dr. Aneesh Mehta, chief of infectious diseases services at Atlanta’s Emory University Hospital, said Emory is focusing supplies on patients likely to benefit the most. “I am not terribly impressed with the study,” said Dr. Adarsh Bhimraj, an infectious disease specialist at the Cleveland Clinic. He said he remains “skeptical” about using remdesivir in patients with moderate COVID, especially given the price.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

Reuters /  🏆 2. in US

 

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

U.S. set to end enhanced screening of some international travelers for COVID-19: sourcesU.S. set to end enhanced screening of some international travelers for COVID-19: sourcesThe U.S. government is set to end enhanced screening of some international passengers for COVID-19 and drop requirements that travelers coming from the targeted countries arrive at 15 designated U.S. airports, according to U.S. and airline officials and a government document seen by Reuters.
Read more »

AstraZeneca's COVID-19 vaccine trial has been stopped after an illnessAstraZeneca's COVID-19 vaccine trial has been stopped after an illnessIt may seem surprising to stop a multimillion-dollar, 30,000-person trial because one person fell ill, but 'it's not at all unprecedented,' said Dr. Francis Collins, director of the National Institutes of Health. Here's what we know.
Read more »

Bob Woodward criticized for not releasing Trump's COVID-19 comments soonerBob Woodward criticized for not releasing Trump's COVID-19 comments soonerBob Woodward was criticized for not releasing President Trump's COVID-19 comments sooner. In an interview with AP, Woodward said he needed time to ensure that the president's remarks were accurate.
Read more »

Netflix ‘Transatlantic 473’ Shoot in Prague Shut Down Temporarily After COVID-19 Diagnosis (EXCLUSIVE)Netflix ‘Transatlantic 473’ Shoot in Prague Shut Down Temporarily After COVID-19 Diagnosis (EXCLUSIVE)The Prague shoot for Netflix’s German-English film “Transatlantic 473” has been temporarily shut down after an extra tested positive for COVID-19, Variety can reveal. With the Czech Republic …
Read more »

WSJ News Exclusive | Rural California Counties Accuse Newsom of Withholding Covid-19 FundsWSJ News Exclusive | Rural California Counties Accuse Newsom of Withholding Covid-19 FundsLeaders of some rural California counties are accusing Gov. Gavin Newsom of improperly withholding federal coronavirus relief funds to force them to slow business reopenings.
Read more »



Render Time: 2026-06-07 14:42:43